Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Immunotherapy Against Lung Cancer : Emerging Opportunities and Challenges / / edited by Shvetank Bhatt, Rajaraman Eri Eri, Bey-Hing Goh, Keshav Raj Paudel, Terezinha de Jesus Andreoli Pinto, Kamal Dua
| Immunotherapy Against Lung Cancer : Emerging Opportunities and Challenges / / edited by Shvetank Bhatt, Rajaraman Eri Eri, Bey-Hing Goh, Keshav Raj Paudel, Terezinha de Jesus Andreoli Pinto, Kamal Dua |
| Autore | Bhatt Shvetank |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (393 pages) |
| Disciplina | 616.994 |
| Altri autori (Persone) |
EriRajaraman Eri
GohBey-Hing PaudelKeshav Raj Andreoli PintoTerezinha de Jesus DuaKamal |
| Collana | Medicine Series |
| Soggetto topico |
Cancer - Treatment
Tumors - Immunological aspects Cancer Therapy Tumour Immunology |
| ISBN |
9789819971411
9819971411 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1_An introduction to Lung cancer -- Chapter 2_Immunobiology of Lung cancer -- Chapter 3_Evolution of Lung cancer treatment from classical chemotherapy to advanced immunotherapy -- Chapter 4_Recent advances in the immunotherapy of Lung cancer -- Chapter 5_PD-1/PD-L1 inhibitors for the treatment of Lung cancer -- Chapter 6_CTLA-4 inhibitors for the treatment of Lung cancer -- Chapter 7_Adoptive T cell therapy for the treatment of Lung cancer -- Chapter 8_LAG-3 inhibitors for the treatment of Lung cancer -- Chapter 9_IDO and TGF-β inhibitors for the treatment of Lung cancer -- Chapter 10_OX40 and CD40 agonists for the treatment of Lung cancer -- Chapter 11_ICOS and GITR agonists for the treatment of Lung cancer -- Chapter 12_Vaccines and oncolytic virus for the treatment of Lung cancer.-Chapter 13_Targeting Toll-like receptors for the treatment of Lung cancer -- Chapter 14_Current and future perspectives of combining chemotherapy and stereotactic body radiation therapy with immunotherapy -- Chapter 15_Synergistic potential of PD-1/PD-L1 inhibitors and CTLA-4 inhibitors for the treatment of Lung cancer -- Chapter 16_Synergistic potential of antigen-specific vaccines and immunomodulatory agents for the treatment of Lung cancer -- Chapter 17_Important biomarkers for better evaluation of checkpoint inhibitors and another immunotherapy in Lung cancer -- Chapter 18_Insight on the clinical trials of immunotherapy for the treatment of Lung cancer -- Chapter 19_Future perspectives of the Cancer Immunotherapy for the treatment of Lung cancer. |
| Record Nr. | UNINA-9910853990503321 |
Bhatt Shvetank
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Immunotherapy Against Lung Cancer [[electronic resource] ] : Emerging Opportunities and Challenges / / edited by Shvetank Bhatt, Rajaraman Eri Eri, Bey-Hing Goh, Keshav Raj Paudel, Terezinha de Jesus Andreoli Pinto, Kamal Dua
| Immunotherapy Against Lung Cancer [[electronic resource] ] : Emerging Opportunities and Challenges / / edited by Shvetank Bhatt, Rajaraman Eri Eri, Bey-Hing Goh, Keshav Raj Paudel, Terezinha de Jesus Andreoli Pinto, Kamal Dua |
| Autore | Bhatt Shvetank |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (393 pages) |
| Disciplina | 616.994 |
| Altri autori (Persone) |
EriRajaraman Eri
GohBey-Hing PaudelKeshav Raj Andreoli PintoTerezinha de Jesus DuaKamal |
| Soggetto topico |
Cancer - Treatment
Tumors - Immunological aspects Cancer Therapy Tumour Immunology |
| ISBN | 981-9971-41-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1_An introduction to Lung cancer -- Chapter 2_Immunobiology of Lung cancer -- Chapter 3_Evolution of Lung cancer treatment from classical chemotherapy to advanced immunotherapy -- Chapter 4_Recent advances in the immunotherapy of Lung cancer -- Chapter 5_PD-1/PD-L1 inhibitors for the treatment of Lung cancer -- Chapter 6_CTLA-4 inhibitors for the treatment of Lung cancer -- Chapter 7_Adoptive T cell therapy for the treatment of Lung cancer -- Chapter 8_LAG-3 inhibitors for the treatment of Lung cancer -- Chapter 9_IDO and TGF-β inhibitors for the treatment of Lung cancer -- Chapter 10_OX40 and CD40 agonists for the treatment of Lung cancer -- Chapter 11_ICOS and GITR agonists for the treatment of Lung cancer -- Chapter 12_Vaccines and oncolytic virus for the treatment of Lung cancer.-Chapter 13_Targeting Toll-like receptors for the treatment of Lung cancer -- Chapter 14_Current and future perspectives of combining chemotherapy and stereotactic body radiation therapy with immunotherapy -- Chapter 15_Synergistic potential of PD-1/PD-L1 inhibitors and CTLA-4 inhibitors for the treatment of Lung cancer -- Chapter 16_Synergistic potential of antigen-specific vaccines and immunomodulatory agents for the treatment of Lung cancer -- Chapter 17_Important biomarkers for better evaluation of checkpoint inhibitors and another immunotherapy in Lung cancer -- Chapter 18_Insight on the clinical trials of immunotherapy for the treatment of Lung cancer -- Chapter 19_Future perspectives of the Cancer Immunotherapy for the treatment of Lung cancer. |
| Record Nr. | UNINA-9910845494503321 |
|
Bhatt Shvetank
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Medicinal Plants for Lung Diseases : A Pharmacological and Immunological Perspective / / edited by Kamal Dua, Srinivas Nammi, Dennis Chang, Dinesh Kumar Chellappan, Gaurav Gupta, Trudi Collet
| Medicinal Plants for Lung Diseases : A Pharmacological and Immunological Perspective / / edited by Kamal Dua, Srinivas Nammi, Dennis Chang, Dinesh Kumar Chellappan, Gaurav Gupta, Trudi Collet |
| Edizione | [1st ed. 2021.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2021 |
| Descrizione fisica | 1 online resource (625 pages) |
| Disciplina | 616.248 |
| Collana | Biomedical and Life Sciences Series |
| Soggetto topico |
Human physiology
Pharmaceutical chemistry Drug delivery systems Human Physiology Pharmaceutics Drug Delivery |
| ISBN | 981-336-850-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Immunopathology of respiratory diseases -- Chapter 2. Introduction to Chronic Respiratory Diseases: A Pressing Need for Novel Therapeutic Approaches -- Chapter 3. Role of Indian Herbal Medicine in the treatment of Pulmonary Diseases -- Chapter 4. Asthma-induced inflammatory responses and reversal by botanicals -- Chapter 5. Medicinal plants in targeting asthma -- Chapter 6. Incipient need of medicinal plants in targeting chronic obstructive pulmonary disease -- Chapter 7. Utilization of Natural Compounds for Treatment of Tuberculosis-I -- Chapter 8. Medicinal plants in the treatment of Tuberculosis-II -- Chapter 9. Medicinal Plants in the Treatment of tuberculosis-III -- Chapter 10.Natural compounds as versatile potential therapeutic agents of lung cancer -- Chapter 11. Exploring the potential of medicinal plants in Lung Cancer -- Chapter 12. Effect of Medicinal Plants against Lung Cancer -- Chapter 13. Medicinal Plants used in the treatment of pulmonary hypertension- I -- Chapter 14.Medicinal Plants used in the treatment of pulmonary hypertension-II -- Chapter 15. Herbal bioactives for the treatment of idiopathic pulmonary fibrosis -- Chapter 16. Medicinal Plants targeting Bronchitis -- Chapter 17. Role of medicinal plants in the treatment of pulmonary edema -- Chapter 18. Medicinal Plants Used in the Treatment of Influenza a Virus Infections -- Chapter 19. Medicinal Plants used in the treatment of influenza A virus infections -- Chapter 20. COVID-19 pandemic panic: prophylactic as well as therapeutic management with traditional ethnic phytopharmaceuticals with challenging nano-spray inhaler and advanced drug delivery system -- Chapter 21. Targeting SARS-CoV2 novel corona (COVID-19) virus infection using medicinal plants -- Chapter 22. Promising plant based bioactive natural products in combating SARS-CoV2 novel corona (COVID-19) virus infection -- Chapter 23. Medicinal plant based advanced drug delivery system for the treatment of chronic lung diseases -- Chapter 24. Medicinal Plant Based Advanced Drug Delivery System for the Treatment of Chronic Lung Diseases -- Chapter 25. Application of nanodrugs derived from active metabolites of medicinal plants for the treatment of inflammatory and lung diseases: Recent advances. |
| Record Nr. | UNINA-9910494558003321 |
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Role of Oxidative Stress in Pathophysiology of Diseases / / edited by Pawan K. Maurya, Kamal Dua
| Role of Oxidative Stress in Pathophysiology of Diseases / / edited by Pawan K. Maurya, Kamal Dua |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (303 pages) |
| Disciplina | 616.39 |
| Soggetto topico |
Cytology
Stress (Physiology) Human physiology Cancer Diseases Neurosciences Nanotechnology Cellular Stress Human Physiology Cancer Biology Neuroscience |
| ISBN | 981-15-1568-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Oxidative stress and oral diseases -- Chapter 2. Role of Oxidative stress in Chronic Liver Diseases -- Chapter 3. In-vitro and In-vivo Antioxidant activity of nanoparticles -- Chapter 4. Oxidative stress in neurology and neurodegenerative processes -- Chapter 5. The role of oxidative stress in respiratory diseases -- Chapter 6. Role of Synbiotics in alleviating oxidative stress in colorectal cancer -- Chapter 7. Oxidative Stress and Immunological Complexities in Multi-Drug Resistant Tuberculosis -- Chapter 8. Infection-induced Oxidative Stress in Chronic Respiratory Diseases -- Chapter 9. Oxidative stress in neuropsychiatric and neurodegenerative diseases -- Chapter 10. Oxidative stress monitoring in in vitro and in vivo models -- Chapter 11. Effects of Yoga on Aging. |
| Record Nr. | UNINA-9910409682603321 |
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Synbiotics in Human Health: Biology to Drug Delivery / / edited by Kamal Dua
| Synbiotics in Human Health: Biology to Drug Delivery / / edited by Kamal Dua |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (730 pages) |
| Disciplina | 615.6 |
| Soggetto topico |
Pharmacology
Medical care Drug delivery systems Health Care Drug Delivery |
| ISBN | 981-9955-75-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction to Synbiotics -- Role of Synbiotics on modulation of inflammation -- Role of synbiotics in inflammatory lung diseases -- Role of Synbiotics in Neurodegenerative Diseases -- Role of Synbiotics in Gastrointestinal Disorders -- Role of Synbiotics in Cardiovascular diseases -- ROLE OF SYNBIOTICS IN THROMBOTIC DISORDERS -- Role of Synbiotics in Reproductive disorders -- Role of Synbiotics in Metabolic Disorders -- SYNBIOTICS FOR THE PREVENTION AND TREATMENT OF SKIN DISORDERS -- Cellular and Molecular mechanisms involving synbiotics in various disease state -- Clinical Trial with Synbiotics in Various Disease State -- FUTURE PERSPECTIVE AND SAFETY ISSUES OF SYNBIOTICS IN DIFFERENT DISEASES -- Role of nutraceutical-based synbiotics in the biological homeostasis -- Synergistic welfare of synbiotic nutraceuticals on chronic respiratory diseases -- Synergistic welfare of symbiotic nutraceuticals on gut health -- Synergistic welfare of synbiotic nutraceuticals on neurological function -- SynergisticWelfare of Synbiotic Nutraceuticals on Reproductive Health -- Quality Control and Evaluation of Synbiotics Neutraceutical Product -- Toxicological profile of nutraceutical supplements -- TRANSLATIONAL RESEARCH & CLINICAL ADVANCEMENTS WITH NUTRACEUTICAL SUPPLEMENTS -- Regulatory Aspects and Bottlenecks for Nutraceuticals -- Future prospects and advancement in synbiotics containing Nutraceuticals -- Synbiotics and Drug Delivery: An introduction -- Emerging era of “biotics”: Prebiotics, probiotics and synbiotics -- Therapeutic potential of synbiotics in management of various disorders -- Synbiotics: Safety assessment and role in the prevention of diseases -- Synbiotics as a nutraceutical adjuvant: neuroprotective and neurorestorative effects -- Synbiotics: Complementary and synergistic approach against different carcinomas -- SYNBIOTICS IN ORAL DRUG DELIVERY -- Applications of synbiotics as cosmeceuticals -- Advanced drug delivery approaches containing synbiotics -- Ideal Synbiotics: Pharmacokinetic, pharmacodynamic and safety assessment -- Regulatory Aspects of Synbiotics-Based Delivery System -- An update on clinical trials on synbiotics. |
| Record Nr. | UNINA-9910847072203321 |
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Targeting Cellular Signalling Pathways in Lung Diseases / / edited by Kamal Dua, Raimar Löbenberg, Ângela Cristina Malheiros Luzo, Shakti Shukla, Saurabh Satija
| Targeting Cellular Signalling Pathways in Lung Diseases / / edited by Kamal Dua, Raimar Löbenberg, Ângela Cristina Malheiros Luzo, Shakti Shukla, Saurabh Satija |
| Edizione | [1st ed. 2021.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2021 |
| Descrizione fisica | 1 online resource (921 pages) |
| Disciplina | 616.2407 |
| Collana | Biomedical and Life Sciences Series |
| Soggetto topico |
Human physiology
Immune system Cellular signal transduction Respiratory organs Physiology Diseases Human Physiology Immune Cell Signalling Respiratory Physiology |
| ISBN | 981-336-827-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Introduction to Lung Diseases -- Chapter 2. Targeting molecular and cellular mechanisms in asthma.-Chapter 3. Various cellular and molecular axis involved in the pathogenesis of asthma -- Chapter 4. Targeting molecular and cellular mechanisms in steroid resistant asthma -- Chapter 5. Targeting molecular and cellular mechanisms in chronic obstructive pulmonary disease -- Chapter 6. Probing the cellular and molecular mechanisms underlying in the pathogenesis of Chronic Obstructive Pulmonary Disease (COPD) -- Chapter 7. Chronic obstructive pulmonary disease: Molecular basis of pathogenesis and targeted therapeutic approaches -- Chapter 8. Exploring the ‘dormancy-activation switch’ in the tumour microenvironment for metastatic lung cancer: The possible role of microRNA -- Chapter 9. Therapeutic strategies targeting signalling pathways in lung cancer -- Chapter 10. Modulation of signalling pathways byimmunotherapeutics in lung cancer -- Chapter 11. Underpinning the Cellular and Molecular Mechanisms with Nanotheronstics for Lung Cancer -- Chapter 12. Targeting molecular and cellular mechanisms in Idiopathic Pulmonary Fibrosis.-Chapter 13. A refined approach to target the molecular and cellular mechanisms in pulmonary fibrosis.-Chapter 14. Targeting molecular and cellular mechanisms in tuberculosis -- Chapter 15. Cellular and Molecular Mechanisms of Repurposed antidiabetic drug as adjunctive treatment for tuberculosis -- Chapter 16. Targeting host and bacterial signaling pathways in tuberculosis: An effective strategy for the development of novel anti-tubercular therapies -- Chapter 17. Targeting molecular and cellular mechanisms in pulmonary hypertension -- Chapter 18. Targeting molecular and cellular mechanisms in pulmonary arterial hypertension -- Chapter 19. Potential cellular targets associated with the signaling and therapeutics of the pulmonary hypertension -- Chapter 20. Targeting molecular and cellular mechanisms in influenza A virus infections -- Chapter 21. Understanding the Biology of Non-typeable Haemophilus influenzae in Chronic Obstructive Pulmonary Disease through the Lens of Genomics -- Chapter 22. Targeting molecular and cellular mechanisms in rhinovirus infection -- Chapter 23. Targeting molecular and cellular mechanisms in respiratory syncytial virus (RSV) infection -- Chapter 24. Targeting molecular and cellular mechanisms SARS-CoV2 novel corona (COVID-19) virus infection -- Chapter 25. Underpinning the rudimentary mechanisms involved in the pathogenesis of SARS-CoV2 (COVID-19) in human lung cells -- Chapter 26. Targeting molecular and cellular mechanisms in SARS-CoV2 novel corona (COVID-19) virus infection -- Chapter 27. Special features of human lung ACE2 sensitivity to SARS CoV-2 spike glycoprotein -- Chapter 28. Implications of Phosphoinositide 3-kinase (PI3K) Signalling in cellular and molecular mechanisms of respiratory diseases -- Chapter 29. The role of the cholinergic system in lung diseases -- Chapter 30. The Nrf2-Keap1 signaling pathway in lung cancer -- Chapter 31. Role of Toll like receptor (LTR) in molecular and cellular mechanism of respiratory diseases -- Chapter 32. Biomarkers of Oxidative Stress -- Chapter 33. Targeting chronic lung diseases using advanced drug delivery systems -- Chapter 34. Plant based chemical moieties targeting cellular signalling pathways in chronic lung diseases -- Chapter 35. Role of phytoconstituents in targeting cytokines for managing pathophysiology of lung diseases -- Chapter 36. Targeting Cellular Signaling Pathways in Lung Cancer and Role of Phytochemicals as Novel Therapeutic Approach -- Chapter 37. Natural compounds targeting major signalling pathways in lung cancer -- Chapter 38. Drug delivery in respiratory diseases: Current opportunities, Molecular and cellular mechanism, and Future challenges -- Chapter 39. Future prospects and challenges in targeting cellular and molecular mechanisms in respiratory diseases. |
| Record Nr. | UNINA-9910488713203321 |
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Transdermal Applications of Minimally Invasive Drug Delivery Systems : Current Trends and Future Perspectives / / edited by Malakapogu Ravindra Babu, Monica Gulati, Vandana B. Patravale, Hélder Santos, Kamal Dua, Sachin Kumar Singh
| Transdermal Applications of Minimally Invasive Drug Delivery Systems : Current Trends and Future Perspectives / / edited by Malakapogu Ravindra Babu, Monica Gulati, Vandana B. Patravale, Hélder Santos, Kamal Dua, Sachin Kumar Singh |
| Autore | Babu Malakapogu Ravindra |
| Edizione | [1st ed. 2025.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2025 |
| Descrizione fisica | 1 online resource (429 pages) |
| Disciplina | 615.6 |
| Altri autori (Persone) |
GulatiMonica
B. PatravaleVandana SantosHélder DuaKamal Kumar SinghSachin |
| Soggetto topico |
Drug delivery systems
Colloids Biomedical engineering Endoscopic surgery Drug Delivery Gels and Hydrogels Biomedical Devices and Instrumentation Minimally Invasive Surgery |
| ISBN | 981-9662-75-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Introduction to Minimally Invasive Drug Delivery System (MIDDS) -- Chapter 2. Minimally Invasive Injectable Hydrogels -- Chapter 3. Advances in Iontophoresis-based drug delivery -- Chapter 4. Modern perspectives of ultrasound-based drug delivery -- Chapter 5. Thermal ablation-based drug delivery system -- Chapter 6. Acoustic cavitation-based drug delivery -- Chapter 7. Magnetic Hyperthermia Ablation-Based Drug Delivery -- Chapter 8. Advancements in Minimally Invasive Probes for Drug Delivery -- Chapter 9. Recent Developments in microneedle-based Drug Delivery -- Chapter 10. Minimally Invasive Drug Delivery Systems for Delivery of Biological Macromolecules -- Chapter 11. Applications of minimally invasive drug delivery systems -- Chapter 12. Industrial Perspective of Minimally Invasive Drug Delivery System -- Chapter 13. Intellectual property rights in minimally invasive drug delivery system -- Chapter 14. Clinical Approaches of Minimally Invasive Drug Delivery Systems. |
| Record Nr. | UNINA-9911011776003321 |
|
Babu Malakapogu Ravindra
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2025 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||